Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon Jun 24, 2019 1:11am
54 Views
Post# 29854704

RE:RE:RE:RE:RE:RE:RE:RE:Meir lost the vote 1.5 months ago!

RE:RE:RE:RE:RE:RE:RE:RE:Meir lost the vote 1.5 months ago!Relying on long past results/ success while ignoring more recent past faillures and actions or the lack of there of is neither logical nor prudent. Regretably that is the hard lesson that I have learned by buying GUD."my fault"  When JG resigns or gets pushed GUD may have a future if I am arround. For the past 4-5 Years the $800,000 M in cash should have returned at least 5-6% per Year to GUD, copound that and calculate what we have all lost.  It's not an oppinion its simple math. Does JG gets it? I do not think so. Did Palladin have that kind of cash at hand at the start? No thus GUD is a different play and different times and one that JG does not seam to know how to play it. The investement universe has changed many times over the past two decades. Did JG adapt to it, so far it does not seam to be the case. Does JG means well? I am sure he does but so what? It does not help GUD invetors. 
Bullboard Posts